{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:04:41Z","timestamp":1789142681882,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alzheimer's Therapeutic Research Initiative"},{"name":"Alzheimer's Disease Cooperative Study"},{"DOI":"10.13039\/100008444","name":"Parkinson Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008444","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000864","name":"Michael J Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Parkinson Council"},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.parkreldis.2019.11.009","type":"journal-article","created":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T11:37:57Z","timestamp":1573472277000},"page":"119-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies"],"prefix":"10.1016","volume":"69","author":[{"given":"Sarah","family":"Horn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayley","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon X.","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3659-0244","authenticated-orcid":false,"given":"Nabila","family":"Dahodwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2019.11.009_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group","volume":"22","author":"Ravina","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson's disease","volume":"289","author":"F\u00e9nelon","year":"2009","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib4","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib5","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson disease?: a prospective population-based long-term study","volume":"75","author":"Forsaa","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib6","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1007\/s00702-009-0302-1","article-title":"Admission of Parkinsonian patients to a neurological ward in a community hospital","volume":"116","author":"Klein","year":"2009","journal-title":"J. Neural Transm. (Vienna, Austria: 1996)"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1532-5415.2000.tb06891.x","article-title":"Predictors of nursing home placement in Parkinson's disease: a population\u2010based, prospective study","volume":"48","author":"Aarsland","year":"2000","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","article-title":"Caregiver-burden in Parkinson's disease is closely associated with psychiatric symptoms, falls, and disability","volume":"12","author":"Schrag","year":"2006","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.parkreldis.2007.05.009","article-title":"A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson's disease patients without dementia","volume":"14","author":"McKinlay","year":"2007","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"The movement disorder society evidence\u2010based medicine review update: treatments for the non\u2010motor symptoms of Parkinson's disease","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib11","doi-asserted-by":"crossref","first-page":"504","DOI":"10.4088\/JCP.v66n0514","article-title":"Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias","volume":"66","author":"Aarsland","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamaneurol.2016.0031","article-title":"Association of antipsychotic use with mortality risk in patients with Parkinson disease","volume":"73","author":"Weintraub","year":"2016","journal-title":"JAMA Neurology"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archneurol.2011.139","article-title":"Patterns and trends in antipsychotic prescribing for Parkinson disease psychosis","volume":"68","author":"Weintraub","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib14","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1212\/01.wnl.0000260060.60870.89","article-title":"Quetiapine for agitation or psychosis in patients with dementia and parkinsonism","volume":"68","author":"Kurlan","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0278-5846(03)00040-X","article-title":"Quetiapine treatment of psychotic symptoms and aggressive behavior in patients with dementia with Lewy bodies: a case series","volume":"27","author":"Takahashi","year":"2003","journal-title":"Progress in Neuropsychopharmacology & Biological Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1176\/appi.ajp.2015.14121582","article-title":"Pharmacological management of Lewy body dementia: a systematic review and meta-analysis","volume":"172","author":"Stinton","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib17","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1517\/14656566.2013.819345","article-title":"Pimavanserin for the treatment of Parkinson's disease psychosis","volume":"14","author":"Friedman","year":"2013","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib18","article-title":"Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial","volume":"13","author":"Cummings","year":"2013","journal-title":"The Lancet"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/WNF.0000000000000219","article-title":"A retrospective study of pimavanserin use in a movement disorders clinic","volume":"40","author":"Friedman","year":"2017","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/WNF.0000000000000296","article-title":"Pimavanserin for psychotic symptoms in people with parkinsonism: a second chart review","volume":"41","author":"Friedman","year":"2018","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib21","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s10072-018-3500-5","article-title":"Pimavanserin use in a movement disorders clinic: a single-center experience","volume":"39","author":"Mahajan","year":"2018","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40266-019-00655-y","article-title":"Pimavanserin for psychosis in Parkinson's disease-related disorders: a retrospective chart review","volume":"36","author":"Sellers","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib23","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1212\/WNL.0000000000006396","article-title":"Mortality in patients with Parkinson disease psychosis receiving pimavanserin and quetiapine","volume":"91","author":"Moreno","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2019.11.009_bib24","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib25","first-page":"112","article-title":"Duopa--a carbidopa\/levodopa enteral suspension for Parkinson's disease","volume":"57","author":"AbbVie Inc","year":"2015","journal-title":"Med. Lett. Drugs Ther."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib26","unstructured":"R Pahwa, KE Lyons, RA Hauser, S Fahn, J Jankovic, E Pourcher, et al. Parkinsonism & Related Disorders."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2147\/NDT.S153321","article-title":"Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson's disease","volume":"14","author":"Hauser","year":"2018","journal-title":"Neuropsychiatric Dis. Treat."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib28","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/mds.23861","article-title":"Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease","volume":"26","author":"Hauser","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib29","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/pgmj.2004.032029","article-title":"Psychosis in Parkinson's disease","volume":"81","author":"Thanvi","year":"2005","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.parkreldis.2019.11.009_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjpo.bp.115.000927","article-title":"Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis","volume":"1","author":"Jethwa","year":"2015","journal-title":"BJPsych open"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019304857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802019304857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:17:39Z","timestamp":1761178659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802019304857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":30,"alternative-id":["S1353802019304857"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.009","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pimavanserin versus quetiapine for the treatment of psychosis in Parkinson's disease and dementia with Lewy bodies","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2019.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}